Revenue Recognition and Accounts Receivable - Additional Information (Detail) € in Millions				1 Months Ended		12 Months Ended
	Sep. 30, 2022	Oct. 01, 2021	Jan. 01, 2020 USD ($)	Apr. 30, 2020 USD ($)	Jun. 30, 2019 USD ($)	Dec. 31, 2020 USD ($)	Dec. 31, 2020 EUR (€)	Dec. 31, 2019 USD ($)	Dec. 31, 2019 EUR (€)	Dec. 31, 2018 USD ($)	Dec. 31, 2018 EUR (€)
Revenue Recognition And Accounts Receivable [Line Items]
Marketing service fees						$ 53,475,000		$ 62,891,000		$ 57,453,000
Cost of sales						101,889,000		100,607,000		96,628,000
Sale of receivables						9,600,000	€ 8.3	10,900,000	€ 9.8	11,500,000	€ 9.8
Estimated related fees						300,000		300,000		300,000
CARES Act of 2020 funds received				$ 13,900,000		13,851,000
Net sales						406,562,000		459,955,000		453,042,000
Other Contract Assets [Member]
Revenue Recognition And Accounts Receivable [Line Items]
Other contract assets impairment						0		0
Other Current Liabilities
Revenue Recognition And Accounts Receivable [Line Items]
CARES Act of 2020 funds received						9,800,000
Other Noncurrent Liabilities
Revenue Recognition And Accounts Receivable [Line Items]
CARES Act of 2020 funds received						4,000,000.0
Other Long-Term Assets [Member]
Revenue Recognition And Accounts Receivable [Line Items]
Other contract assets						2,000,000.0		3,700,000
Scenario Forecast [Member]
Revenue Recognition And Accounts Receivable [Line Items]
Medicare recoupment	0.50	0.25
Frequency of recoupment	6	11
Performance Obligations [Member]
Revenue Recognition And Accounts Receivable [Line Items]
Net sales						0
Puerto Rico [Member]
Revenue Recognition And Accounts Receivable [Line Items]
Proceeds from settlement of trade accounts receivable					$ 1,400,000
Accounts receivable					2,500,000
Contractual allowances					400,000
Recovery of the allowance for expected credit losses					$ 1,000,000.0
ASU 2016-13 [Member]
Revenue Recognition And Accounts Receivable [Line Items]
Increase (decrease) to allowance for expected credit losses			$ 1,100,000
Increase (decrease) in deferred income taxes			200,000
Decrease in retained earnings			$ 900,000
Shipping and Handling Costs [Member]
Revenue Recognition And Accounts Receivable [Line Items]
Cost of sales						2,400,000		2,800,000		2,700,000
Biologics [Member]
Revenue Recognition And Accounts Receivable [Line Items]
Marketing service fees						$ 53,500,000
Marketing service fee as percentage of segment revenues						96.00%	96.00%
Net sales						$ 55,482,000		$ 65,496,000		$ 59,684,000